News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AVANIR Pharmaceuticals (AVNR) to Participate in Two Upcoming Investor Conferences



5/22/2013 7:28:58 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALISO VIEJO, Calif., May 22, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following conferences.

  • Deutsche Bank 38th Annual Health Care Conference
    • Presentation date: Wednesday May 29, 2013
    • Presentation time: 12:00 p.m. P.T.
  • Jefferies 2013 Global Healthcare Conference
    • Presentation date: Wednesday June 5, 2013
    • Presentation time: 8:30 a.m. E.T.

A live webcast and 30-day archive of these presentations will be available at http://ir.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

SOURCE Avanir Pharmaceuticals, Inc.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES